MAIA Biotechnology (MAIA) Interest Expenses (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Interest Expenses of $329000.0 for Q1 2026, up 39.3% year-over-year from $236183.0 in Q1 2025, and down 98.56% quarter-over-quarter from $22.9 million in Q4 2025.
MAIA Biotechnology (MAIA) Interest Expenses (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Interest Expenses for 6 consecutive years, with $329000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 39.3% year-over-year to $329000.0; the TTM figure through Mar 2026 stood at $329000.0 (up 39.3% YoY), while the FY2025 annual figure was $22.9 million, up 50.67% from the prior year.
- Interest Expenses retreated to $329000.0 in Q1 2026 per MAIA's latest filing, from $22.9 million in the prior quarter.
- Across five years, Interest Expenses topped out at $22.9 million in Q4 2025 and bottomed at -$28.0 in Q4 2024.
- Historically, Interest Expenses has averaged $5.6 million across 5 years, with a median of $2.1 million in 2023.
- On a YoY basis, Interest Expenses climbed as much as 81727103.57% in 2025 and fell as far as 96.42% in 2025.
- MAIA Biotechnology's Interest Expenses stood at $5147.0 in 2022, then jumped by 41286.21% to $2.1 million in 2023, then slumped by 100.0% to -$28.0 in 2024, then jumped by 81727103.57% to $22.9 million in 2025, then slumped by 98.56% to $329000.0 in 2026.
- Business Quant data shows MAIA's Interest Expenses at $329000.0 in Q1 2026, $22.9 million in Q4 2025, and $252245.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 513,032.00 |
| Jun 30, 2026 | 513,032.00 |
| Mar 31, 2026 | 329,000.00 |
| Mar 31, 2026 | 329,000.00 |
| Dec 31, 2025 | 22.88 Mn |
| Dec 31, 2025 | 22.88 Mn |
| Sep 30, 2025 | 252,245.00 |
| Sep 30, 2025 | 252,245.00 |
| Jun 30, 2025 | 627,620.00 |
| Jun 30, 2025 | 627,620.00 |
| Mar 31, 2025 | 236,183.00 |
| Mar 31, 2025 | 236,183.00 |
| Dec 31, 2024 | -28.00 |
| Dec 31, 2024 | -28.00 |
| Sep 30, 2024 | 7.04 Mn |
| Sep 30, 2024 | 7.04 Mn |
| Jun 30, 2024 | 11.60 Mn |
| Jun 30, 2024 | 11.60 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |